| Mepha Pharma AG - Olmesartan-HCT-Mepha Teva 40/25 mg, Filmtabletten | | 68456 | | 04 | | Olmesartan-HCT-Mepha Teva 40/25 mg | | Filmtabletten | | C09DA08 | | Olmesartan medoxomil and diuretics | | 28.04.2022 | | |
| | Composition | | olmesartanum medoxomilum 40.0 mg, hydrochlorothiazidum 25.0 mg, lactosum monohydricum 277.10 mg, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, lactosum monohydricum 2.772 mg, macrogolum 3350, triacetinum, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Hydrochlorothiazide | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Hydrochlorothiazide | 25 mg | | Olmesartan Medoxomil | 40 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 2.772 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Olmesartanum Medoxomilum | 40 mg | | | Pro Compresso Obducto | | | | Titanium Dioxide | | | | Triacetinum | | |
| |
| |
|
